feeling lightheaded on semaglutide Weak Semaglutide: Causes and Management Strategies How To Track My Semaglutide

One research letter published in JAMA Oncology last year, for example, suggests GLP-1 drugs might reduce the risk of colon cancer, even among people who are not overweight

Although GI side effects such as nausea, vomiting, constipation, and delayed gastric emptying are well documented with GLP-1/GIP agonists, small bowel obstruction (SBO) remains a rare and underreported complication [6]

Trapp, S., & Brierley, D

Yes, Zepbound has been approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidemia